Статус: | Completed |
Фаза: | Phase 4 |
Начало: | 1 октября 2010 г. |
Окончание: | 1 мая 2013 г. |
Описание: | The study will investigate whether combination antiretroviral therapy of raltegravir and 3TC/ABC is effective and safe to use in tuberculosis (TB)/HIV co-infected adults receiving rifabutin-containing, first-line antituberculous treatment. Hypothesis:Combination antiretroviral therapy of raltegravir and 3TC/ABC and is effective and safe to use in tuberculosis (TB)/HIV co-infected adults receiving rifabutin-based first-line antituberculous treatment. |
смотреть на ClinicalTrials.gov |